CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $290,749 | -40.7% | 173,065 | -0.0% | 0.00% | – |
| Q2 2023 | $489,997 | -42.9% | 173,144 | -1.0% | 0.00% | -100.0% |
| Q1 2023 | $858,602 | -54.5% | 174,868 | -0.6% | 0.00% | -50.0% |
| Q4 2022 | $1,888,650 | +13.3% | 175,852 | -1.2% | 0.00% | 0.0% |
| Q3 2022 | $1,667,000 | +7.9% | 178,075 | +5.2% | 0.00% | +100.0% |
| Q2 2022 | $1,545,000 | -20.0% | 169,200 | +6.4% | 0.00% | -50.0% |
| Q1 2022 | $1,931,000 | -0.7% | 158,949 | -0.5% | 0.00% | 0.0% |
| Q4 2021 | $1,945,000 | -24.8% | 159,706 | -4.5% | 0.00% | 0.0% |
| Q3 2021 | $2,585,000 | +15.3% | 167,288 | +6.5% | 0.00% | 0.0% |
| Q2 2021 | $2,242,000 | -30.8% | 157,147 | +5.3% | 0.00% | -50.0% |
| Q1 2021 | $3,239,000 | +42.7% | 149,195 | -0.6% | 0.00% | +33.3% |
| Q4 2020 | $2,270,000 | +19.3% | 150,043 | +0.3% | 0.00% | 0.0% |
| Q3 2020 | $1,903,000 | -26.6% | 149,542 | -1.4% | 0.00% | -40.0% |
| Q2 2020 | $2,594,000 | +31.7% | 151,691 | +1.8% | 0.01% | +25.0% |
| Q1 2020 | $1,969,000 | -17.6% | 149,080 | +0.5% | 0.00% | 0.0% |
| Q4 2019 | $2,391,000 | -4.1% | 148,392 | +8.8% | 0.00% | -20.0% |
| Q3 2019 | $2,494,000 | -15.3% | 136,422 | -0.4% | 0.01% | -16.7% |
| Q2 2019 | $2,945,000 | +16.4% | 136,972 | +6.2% | 0.01% | 0.0% |
| Q1 2019 | $2,531,000 | +60.8% | 129,012 | +6.5% | 0.01% | +50.0% |
| Q4 2018 | $1,574,000 | -45.9% | 121,097 | -0.4% | 0.00% | -42.9% |
| Q3 2018 | $2,911,000 | +24.2% | 121,557 | -0.7% | 0.01% | +16.7% |
| Q2 2018 | $2,344,000 | +68.1% | 122,427 | +8.8% | 0.01% | +50.0% |
| Q1 2018 | $1,394,000 | +53.4% | 112,571 | +51.6% | 0.00% | +33.3% |
| Q4 2017 | $909,000 | +18.2% | 74,236 | +32.2% | 0.00% | 0.0% |
| Q3 2017 | $769,000 | -14.9% | 56,145 | -4.4% | 0.00% | 0.0% |
| Q2 2017 | $904,000 | +87.6% | 58,755 | +118.3% | 0.00% | 0.0% |
| Q1 2017 | $482,000 | – | 26,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |